Viewing StudyNCT00856674



Ignite Creation Date: 2024-05-05 @ 9:16 PM
Last Modification Date: 2024-10-26 @ 10:02 AM
Study NCT ID: NCT00856674
Status: TERMINATED
Last Update Posted: 2010-06-02
First Post: 2009-03-04

Brief Title: Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Sponsor: Osprey Pharmaceuticals USA Inc
Organization: Osprey Pharmaceuticals USA Inc

Conditions & Keywords Data

Conditions:
Name
Proteinuria
IGA Nephropathy
Keywords:
Name View
phase-1 View
IgA nephropathy View
chemokine fusion protein View
leukocyte population modulator View